2025 India Artificial Intelligence (Ai) In Drug Discovery Market Revenue Opportunities Report
Description
The 2025 India Artificial Intelligence (Ai) In Drug Discovery Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Artificial Intelligence (AI) in Drug Discovery Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Artificial Intelligence in Drug Discovery market in India include Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Terralogic Biosciences, and Bugworks Research. Sun Pharma, Mumbai-based, leads in pharmaceutical manufacturing and integrates AI-driven drug discovery to accelerate novel therapeutics development. Dr. Reddy’s Labs is recognized for advancing biosimilars and novel molecule trials with AI technologies. Terralogic Biosciences utilizes machine learning models for drug repurposing, enhancing identification of new applications for existing drugs to reduce treatment time-to-market. Bugworks Research focuses on AI to address antimicrobial resistance, a critical healthcare challenge in India.
India’s AI drug discovery ecosystem thrives due to rich genomic datasets, government initiatives like the India AI-Biotech Hub, and cost-effective R&D. These companies leverage AI platforms for drug target identification, clinical data analyses, and predictive modeling, positioning India as a global biotech hub. Sun Pharma and Dr. Reddy’s also collaborate internationally to enhance AI-driven pharmaceutical innovation, while startups like Terralogic and Bugworks emphasize AI in precision medicine, diagnostics, and resistance management. This dynamic blend of established pharmaceutical giants and emerging AI biotech companies propels India’s leadership in AI-enabled drug discovery.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Artificial Intelligence (AI) in Drug Discovery Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Artificial Intelligence in Drug Discovery market in India include Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Terralogic Biosciences, and Bugworks Research. Sun Pharma, Mumbai-based, leads in pharmaceutical manufacturing and integrates AI-driven drug discovery to accelerate novel therapeutics development. Dr. Reddy’s Labs is recognized for advancing biosimilars and novel molecule trials with AI technologies. Terralogic Biosciences utilizes machine learning models for drug repurposing, enhancing identification of new applications for existing drugs to reduce treatment time-to-market. Bugworks Research focuses on AI to address antimicrobial resistance, a critical healthcare challenge in India.
India’s AI drug discovery ecosystem thrives due to rich genomic datasets, government initiatives like the India AI-Biotech Hub, and cost-effective R&D. These companies leverage AI platforms for drug target identification, clinical data analyses, and predictive modeling, positioning India as a global biotech hub. Sun Pharma and Dr. Reddy’s also collaborate internationally to enhance AI-driven pharmaceutical innovation, while startups like Terralogic and Bugworks emphasize AI in precision medicine, diagnostics, and resistance management. This dynamic blend of established pharmaceutical giants and emerging AI biotech companies propels India’s leadership in AI-enabled drug discovery.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
